EUVIMEDEUVIMED entdecken
Crossref

Quantitative genotoxicity assessment of N-nitrosodimethylamine in mice by error-corrected next-generation sequencing and DNA methylation quantification for toxicity threshold determination

Xinyue You, Chen Sun, Yiyi Cao, Jing Xi, Weiying Liu, Jiaying Wu, Jiang Zheng, Yang Luan iD

Archives of Toxicology · 2025

DOI: 10.1007/s00204-025-04166-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, 2025. Verfasst von Xinyue You und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Children's Hospital, Shanghai Institute of Medical Genetics, Shanghai Jiao Tong University School of Medicine, Shanghai, 200040, China. Hauptthemen laut MEDLINE: Dimethylnitrosamine, DNA Methylation, Carcinogens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Medical Products Administration (NMPA) Key Laboratory for Quality Analysis of Chemical Drug Preparations, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The contamination of N-nitrosamines (N-NAs) in pharmaceuticals has raised global concerns, due to potential carcinogenic risks. N-nitrosodimethylamine (NDMA) is a rodent carcinogen and the most prevalent N-NAs impurity in drug products. Current acceptable intake of NDMA (96 ng/day) is a simple linear extrapolation from rodent carcinogenicity data, which may not comprehensively characterize its genotoxic potential in humans. Most N-NAs react with DNA to form DNA adducts after metabolic activation, leading to mutations and carcinogenesis. Here, we combined high-accuracy LC-MS/MS with error-corrected next-generation sequencing (ecNGS) to assess NDMA-induced DNA adduction and somatic mutations in mice using the quantitative benchmark dose (BMD) approach. NDMA induced dose-dependent increases in both DNA adduction and somatic mutations in liver tissues, with significant increases in mutation frequencies observed at ≥ 1 mg/kg/day. NDMA induced mutations mainly with CG > TA and TA > CG transitions, exhibiting a signature resembling COSMIC signature 11, the mutational profile of alkylating agents. BMD50 (90% CI) was estimated as 0.08-0.32 mg/kg for N7-methylguanine and 1.64-3.83 mg/kg for mutations. Permitted daily exposure (PDE) for NDMA was calculated from the lower confidence limit of BMD50 (BMDL50) of genotoxic endpoints using appropriate uncertainty factors, revealing a PDE value of 245 ng/day for NDMA-induced mutation. This PDE value was higher than the limit of 96 ng/day recommended by regulatory agencies. Based on the quantitative genotoxicity assessment, our findings may improve the risk assessment of NDMA-contaminated pharmaceuticals and demonstrate the potential implementation of ecNGS in regulatory decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DimethylnitrosamineDNA MethylationCarcinogensAnimalsMiceDNA AdductsHigh-Throughput Nucleotide SequencingDose-Response Relationship, DrugMaleMutagenicity TestsLiverMutationTandem Mass SpectrometryFemaleRisk Assessment

Stichwörter der Autor:innen

N-nitrosodimethylamineDNA methylationError-corrected next-generation sequencingQuantitative genotoxicity assessment

Substanzen

DimethylnitrosamineDNA AdductsCarcinogens

Autor:innen und Institutionen

  • Shanghai Children's Hospital, Shanghai Institute of Medical Genetics, Shanghai Jiao Tong University School of Medicine, Shanghai, 200040, China.
  • School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • NHC Key Laboratory of Medical Embryogenesis and Developmental Molecular Biology & Shanghai Key Laboratory of Embryo and Reproduction Engineering, Shanghai, 200040, China.
  • College of Pharmacy, Dalian Medical University, Dalian, 116044, China.
  • Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, China.
  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Educati…

ORCID-Profile: Yang Luan

Förderung

  • National Natural Science Foundation of China
  • National Medical Products Administration (NMPA) Key Laboratory for Quality Analysis of Chemical Drug Preparations
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

You, X., Sun, C., Cao, Y., Xi, J., Liu, W., Wu, J., Zheng, J., & Luan, Y. (2025). Quantitative genotoxicity assessment of N-nitrosodimethylamine in mice by error-corrected next-generation sequencing and DNA methylation quantification for toxicity threshold determination. Archives of Toxicology. https://doi.org/10.1007/s00204-025-04166-1

Vancouver

You X, Sun C, Cao Y, Xi J, Liu W, Wu J, et al. Quantitative genotoxicity assessment of N-nitrosodimethylamine in mice by error-corrected next-generation sequencing and DNA methylation quantification for toxicity threshold determination. Archives of Toxicology. 2025. doi:10.1007/s00204-025-04166-1

BibTeX
@article{You2025,
  author = {You, Xinyue and Sun, Chen and Cao, Yiyi and Xi, Jing and Liu, Weiying and Wu, Jiaying and Zheng, Jiang and Luan, Yang},
  title = {Quantitative genotoxicity assessment of N-nitrosodimethylamine in mice by error-corrected next-generation sequencing and DNA methylation quantification for toxicity threshold determination},
  journal = {Archives of Toxicology},
  year = {2025},
  doi = {10.1007/s00204-025-04166-1}
}
Kostenlos starten →